DOCS Company Profile and Key Details

Short-term trend indicators are bullishly aligned (SMA20 -12.41%, SMA50 -32.47%, SMA200 -54.39%). The stock’s 14-day RSI is 25.81 (weak momentum), while the ATR of 1.67 points to higher daily volatility. The stock remains sitting in the mid-range of its 52-week band, trading -67.19% below its high and over 6.67% above its low. Average 10-day trading volume of 3.27 million shares is below the 3-month average of 4.01 million, indicating normal recent market interest.

Doximity, Inc. has 128.86 million shares outstanding. The public float is 127.40 million shares, elevated short interest at 16.11% of float. This equals 20.73 million shares. The short ratio is 5.99 days. Institutional investors hold 103.21% of the float. Insiders own 2.77%. Tangney Jeffrey holds 2.10 million shares, EMERGENCE CAPITAL PARTNERS II LP has 775.00 thousand shares and Spain Kevin has 775.00 thousand shares. Over the past six months, insider transactions show net selling. They sold 26.51 thousand shares across 9 transactions.

Doximity, Inc. (NYSE:DOCS) closed at $21.44 USD, gaining $0.45 (2.14%) from the previous close of $20.99. The stock is currently mid-range between its 52-week high and low $17.15 and $76.51. With a market capitalization of about $4.01 billion, Doximity, Inc. is classified as a mid-cap and shows market-like volatility (beta ~1.29). Key stats such as the average daily volume over the past year has been around 4.04 million shares, in line with its 52-week average. Headquartered in San Francisco, CA, Doximity, Inc. operates in the Healthcare sector and the Medical - Healthcare Information Services industry. Led by CEO Jeffrey A. Tangney, the company employs approximately 880 people and listed since June 24, 2021. Doximity, Inc. provides a digital platform, hosted in the cloud, specifically designed for healthcare practitioners throughout the United States.

Doximity, Inc. last paid a dividend of 0 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around $40.58. This means the shares are trading below this model’s fair value.

Doximity, Inc. generated EPS of $1.19 over the past year. Five-year average earnings growth is 79.45%. Wall Street analysts project EPS growth of 8.55% annually over the next five years. The latest quarter delivered EPS of $0.10. The next quarter is forecast at $0.28. Next year's EPS is expected at $5.83. Analyst sentiment is neutral. Analyst rating data shows there are 21 Strong Buy ratings, 9 Buy ratings, 23 Hold ratings, 1 Sell rating and 2 Strong Sell ratings. Price targets range from $81.00 to $18.00. The high target offers 277.8% upside. The low target suggests -16.04% downside. The mean target is $45.50. This offers 112.22% upside. Doximity, Inc. earnings surprise history is a consistent trend of beating forecasts. The quarter that ended May 13, 2026, missed forecasts by -64.29%. The prior quarter beat by 4.55%. Over the last six quarters, Apple has recorded several small beats. These include 45.16% in February 06, 2025.

Doximity, Inc. trades at a P/E ratio of 20.42, slightly below the S&P 500 average, with a price-to-sales ratio of 6.16 and a price-to-book ratio of 4.13 trading at moderately above to book value. The P/FCF stands at 12.51, also above market averages.

Our AI price prediction model suggests that Doximity, Inc. stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected decline of -9.65%, with price expected at $19.37 by August 11, 2026, within a range of $18.73 to $20.08 3-Month Outlook: Projected fall of -35.96%, reaching $13.73 by October 23, 2026, with a range of $11.54 to $15.10. 1-Year Outlook: Projected gain of 30.55%, with price at $27.99 by July 28, 2027, within a range of $22.07 to $33.20.

Doximity, Inc. (NYSE:DOCS) shares are flat -7.18% year-to-date currently trading near 52-week highs band. Short-term momentum has been negative over the last quarter, despite recent volatility. Valuation shows Doximity, Inc. trading at a premium to the broader market with a P/E of 20.42. Analyst sentiment is cautious, with the majority of ratings in Underperform territory and a mean price target of $47.78, suggesting 122.85% upside. Our AI forecast model points to short-term weakness (-9.65% over two weeks), a medium-term fall (-35.96% over three months), and a longer-term gain (30.55% over one year), with expected trading ranges indicating moderate volatility.